From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
Arizonans Join Leaders From Across the Country to Weigh In On The Reasons For a Medical Device Tax Repeal as the U.S. House of Representatives Prepares to take it to a vote.
Flagship Biosciences, a fast growing pharmaceutical services company based in Flagstaff, AZ, is a leading example of the power of the collaborative nature of the Arizona bioindustry.
Flagship Biosciences acquires IHCtech, a leading provider of research immunohistochemistry and histology services Combining tissue analysis with expert immunohistochemistry completes Flagship’s novel quantitative pathology approaches
Josephine Clark-Curtiss, a researcher at Arizona State University’s Biodesign Institute has been exploring new lines of attack againstMycobacterium tuberculosis, causative agent of tuberculosis.
- Laws of Innovation Series: Negotiating Patent and Know-How License Agreements
- BIO Latin America
- 09/03/2019 - 09/04/2019
- São Paulo
- The Rocky Mountain Life Science Investor & Partnering Conference
- 09/04/2019 - 09/05/2019
- RESI 2019 - Boston
- MDMA’s 12th Annual Medical Technology Executive Forum
- Palo Alto